We firmly believe in the fact that the inhalation preparation is and will be the mainstream product in the market.
Our products will be approved in China and EU from year 2021 and on, and with a global sell, we will be a leading company in inhalation products and eyedrops soon.
Events
-
2023-07-05Nanjing Aureole Pharmaceutical Approved for Marketing the First Procaterol Hydrochloride Inhalation Solution in China
On June 30, 2023, our product Procaterol Hydrochloride Inhalation Solution was approved for marketing (approval No.: H20233837), making it the first of this kind to be launched domestically. Procaterol hydrochloride is a β2 agonist with high selectivity for β2 adrenergic rMore -
2023-06-28Congratulations: Delivery of the First Order of “Dingda-Salbutamol Sulfate Inhalation Solution” by Aureole Pharmaceutical
At 16:00 pm on May 18, 2023, the warehouse completed the delivery of the first order of Dingda-Salbutamol Sulfate Inhalation Solution (2.5 mL: 5 mg) manufactured by Nanjing Aureole Pharmaceutical Co., Ltd. Aureole Pharmaceutical people finally ushered in the official sale of the product afteMore -
2023-06-28Congratulations on the Approval of Marketing of Our Terbutaline Sulfate Nebulizer Inhalation Solution!
We have focused on inhalation product R&D, and the results are prominent! Following the approval of the first product at the end of March, our second product, Terbutaline Sulfate Nebulizer Inhalation Solution with two strengths, was approved for marketing on April 14, with the approval nMore -
2023-06-28Congratulations on the Approval of Marketing of Our Salbutamol Sulfate Inhalation Solution with Two Strengths!
On March 24, 2023, we successfully obtained the manufacturing approvals for Salbutamol Sulfate Inhalation Solution with two strengths, with the approval numbers of Guo. Yao. Zhun. Zi. No. H20233355, and Guo. Yao. Zhun. Zi. No. H20233356 respectively, which are deemed to have passed the consiMore -
2023-06-28Good News! Congratulations to Our Company for Being Selected as “Jiangbei New Area Health Enterprise”
In December 2022, our Company passed the evaluation of “Jiangbei New Area Health Enterprise” and was selected as “Jiangbei New Area Health Enterprise”. Health is an inevitable requirement for the overall development of human beings, a basic condition for econMore -
2023-06-28Good News! Congratulations to Our Company for Being Recognized as the Innovation Company
Our Company was recognized as “Innovation Company” in the third list in 2022. The recognization of “Innovation Company” has strict requirements on product areas, patent achievements, R&D investment, growth indicators and talent structure. We started to prMore -
2021-02-02Aureole's Salbutamol Sulfate Inhalation Solution Recieved CDE Reference Number
The Salbutamol Sulfate Inhalation Solution (2.5ml:2.5mg ) and the Salbutamol Sulfate Inhalation Solution (2.5ml:5mg ), which researched and developed independently by Aureole and is the first product to register, receives the reference number issued by CDE on NovMore